Price Alert

Channel Therapeutics Corp... (PTHS)

NYSE: PTHS · Real-Time Price · USD

22.73

0.14 (0.62%)

At close: Aug 26, 2025, 1:16 PM

Channel Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024
Net Income	-9.04M	-7.36M	-7.96M	-6.03M	-4.33M	-2.56M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.95M	1.99M	1.8M	1.27M	751.53K	292.55K
Other Working Capital	-580.94K	-676.24K	-1.1M	-1.13M	-440.62K	-372.95K
Other Non-Cash Items	-17.81K	-182.49K	328.93K	252.84K	605.63K	605.63K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	5.18M	1.12M	34.63K	-615.33K	-1.97M	-327.75K
Operating Cash Flow	-1.93M	-4.43M	-5.79M	-5.12M	-4.94M	-1.99M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	-426.1K	786.18K	321.43K	475.24K	1.37M	-214.76K
Common Stock Repurchased	-75K	-75K	-166.51K	-166.51K	-91.51K	-91.51K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	-418.48K	793.8K	6.21M	6.28M	7.25M	5.67M
Net Cash Flow	-2.35M	-3.64M	417.05K	1.16M	2.31M	3.67M
Free Cash Flow	-1.93M	-4.43M	-5.79M	-5.12M	-4.94M	-1.99M